Lv2
170 积分 2025-03-17 加入
A proof-of-mechanism trial in asthma with lunsekimig, a bispecific nanobody® molecule
10天前
已完结
Applied Pharmacometrics
1个月前
已完结
Soybean RING‐type E3 ligase GmCHYR16 ubiquitinates the GmERF71 transcription factor for degradation to negatively regulate bicarbonate stress tolerance
1个月前
已完结
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
1个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
1个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
1个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
1个月前
已完结
皖公网安备34019202002308
